The preclinical phase is a critical stage in drug development that occurs before human clinical trials. During this phase, researchers conduct laboratory experiments and animal studies to assess a drug’s safety, biological activity, and potential effectiveness. Data from the preclinical phase is used to support regulatory submissions and determine whether a candidate is suitable for testing in humans, making it a key step in bringing new therapies to market.